V. McLaughlin, R. Channick, B. Walsh, M. Keating, K. Gilder, C. Cabell, P. Klassen, V. Tapson, M. Humbert
{"title":"评估Ralinepag治疗肺动脉高压患者的临床事件时间和运动能力的3期ADVANCE项目的研究设计","authors":"V. McLaughlin, R. Channick, B. Walsh, M. Keating, K. Gilder, C. Cabell, P. Klassen, V. Tapson, M. Humbert","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5074","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":120238,"journal":{"name":"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Study Design of the Phase 3 ADVANCE Program Evaluating Time-to-Clinical Events and Exercise Capacity in Patients with Pulmonary Arterial Hypertension Treated with Ralinepag\",\"authors\":\"V. McLaughlin, R. Channick, B. Walsh, M. Keating, K. Gilder, C. Cabell, P. Klassen, V. Tapson, M. Humbert\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":120238,\"journal\":{\"name\":\"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH\",\"volume\":\"12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5074\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Study Design of the Phase 3 ADVANCE Program Evaluating Time-to-Clinical Events and Exercise Capacity in Patients with Pulmonary Arterial Hypertension Treated with Ralinepag